Clinical Trial

Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial

Name: Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial — clinical trial record (NCT06982690)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

To demonstrate the superior efficacy of spinal anesthesia (SA) versus general anesthesia (GA) according to the delay of time to recurrence in high-risk NMIBC patients up to Week 104 after TURBT.

Trial Details

NCT Number	NCT06982690
Lead Sponsor	National Taiwan University Hospital
Conditions	NMIBC, TURBT, Bladder (Urothelial, Transitional Cell) Cancer, Bladder Cancer Recurrence, Anesthesia, General, Anesthesia,Spinal
Enrollment	370 participants
Start Date	2025-08-01
Primary Completion	2029-11-30 (estimated)
Study Completion	2029-11-30 (estimated)
Updated on ClinicalTrials.gov	2025-05-21